{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:49:17Z","timestamp":1791287357881,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["01D30011"],"award-info":[{"award-number":["01D30011"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jpba.2016.09.036","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T01:57:06Z","timestamp":1475114226000},"page":"72-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dried blood spot analysis of gabapentin as a valid alternative for serum: a bridging study"],"prefix":"10.1016","volume":"132","author":[{"given":"Nele","family":"Sadones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elien","family":"Van Bever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Bortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy E.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-348X","authenticated-orcid":false,"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.09.036_bib0005","series-title":"Down a Stony Road: the Drugscope Street Drug Survey","author":"Daly","year":"2014"},{"key":"10.1016\/j.jpba.2016.09.036_bib0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpba.2016.09.036_bib0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac303205m","article-title":"Dried blood spots: analysis and applications","volume":"85","author":"Demirev","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2016.09.036_bib0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2016.09.036_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC-MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2016.09.036_bib0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10408444.2011.650790","article-title":"Dried blood spots in toxicology: from the cradle to the grave?","volume":"42","author":"Stove","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.jpba.2016.09.036_bib0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40262-014-0150-5","article-title":"Why dried blood spots are an ideal tool for CYP1A2 phenotyping","volume":"53","author":"De Kesel","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2016.09.036_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40263-013-0050-5","article-title":"Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem(R))-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study","volume":"27","author":"Ingels","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpba.2016.09.036_bib0045","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio.13.156","article-title":"Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions","volume":"5","author":"De Kesel","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2016.09.036_bib0050","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4155\/bio.14.156","article-title":"Spot them in the spot: analysis of abused substances using dried blood spots","volume":"6","author":"Sadones","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2016.09.036_bib0055","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4155\/bio.15.139","article-title":"DBS and beyond","volume":"7","author":"Stove","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2016.09.036_bib0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00216-010-4048-2","article-title":"Dried plasma spots as an alternative sample collection technique for the quantitative LC-MS\/MS determination of gabapentin","volume":"398","author":"Kolocouri","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.09.036_bib0065","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/bmc.3217","article-title":"Gas chromatography-electron ionization-mass spectrometry quantitation of valproic acid and gabapentin using dried plasma spots, for therapeutic drug monitoring in in-home medical care","volume":"28","author":"Ikeda","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2016.09.036_bib0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-014-2999-2","article-title":"Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen","volume":"146","author":"Jager","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jpba.2016.09.036_bib0075","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.4155\/bio.15.100","article-title":"Are capillary DBS applicable for therapeutic drug monitoring of common antipsychotics? A proof of concept","volume":"7","author":"Patteet","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2016.09.036_bib0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4155\/bio.15.255","article-title":"A clinical validation study for application of DBS in therapeutic drug monitoring of antidepressants","volume":"8","author":"Berm","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2016.09.036_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/FTD.0b013e31827788c0","article-title":"Rapid quantification of gabapentin pregabalin, and vigabatrin in human serum by ultraperformance liquid chromatography with mass-spectrometric detection","volume":"35","author":"Chahbouni","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2016.09.036_bib0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.chroma.2016.08.057","article-title":"Microwave-assisted on-spot derivatization for gas chromatography-mass spectrometry based determination of polar low molecular weight compounds in dried blood spots","volume":"1465","author":"Sadones","year":"2016","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2016.09.036_bib0095","series-title":"Bioanalytical Method Validation","author":"Food","year":"2016"},{"key":"10.1016\/j.jpba.2016.09.036_bib0100","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2016"},{"key":"10.1016\/j.jpba.2016.09.036_bib0105","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2011"},{"key":"10.1016\/j.jpba.2016.09.036_bib0110","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/clinchem\/39.11.2288","article-title":"Relation between serum and whole-blood ethanol concentrations","volume":"39","author":"Rainey","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2016.09.036_bib0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1208\/s12248-010-9188-y","article-title":"Use of dried blood spots in drug development: pharmacokinetic considerations","volume":"12","author":"Rowland","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2016.09.036_bib0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2125.2010.03668.x","article-title":"Can finger-prick sampling replace venous sampling to determine the pharmacokinetic profile of oral paracetamol?","volume":"70","author":"Mohammed","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2016.09.036_bib0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s002280000179","article-title":"Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin","volume":"56","author":"Gordi","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2016.09.036_bib0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00003088-198917030-00004","article-title":"The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics pharmacodynamics, toxicology and therapeutics (Part I)","volume":"17","author":"Chiou","year":"1989","journal-title":"Clin. Pharmacokinet."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516307099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516307099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:52:01Z","timestamp":1759999921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516307099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"alternative-id":["S0731708516307099"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.09.036","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dried blood spot analysis of gabapentin as a valid alternative for serum: a bridging study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}